SF2312 is a natural phosphonate inhibitor of enolase

Nat Chem Biol. 2016 Dec;12(12):1053-1058. doi: 10.1038/nchembio.2195. Epub 2016 Oct 10.

Abstract

Despite being crucial for energy generation in most forms of life, few if any microbial antibiotics specifically inhibit glycolysis. To develop a specific inhibitor of the glycolytic enzyme enolase 2 (ENO2) for the treatment of cancers with deletion of ENO1 (encoding enolase 1), we modeled the synthetic tool compound inhibitor phosphonoacetohydroxamate (PhAH) into the active site of human ENO2. A ring-stabilized analog of PhAH, in which the hydroxamic nitrogen is linked to Cα by an ethylene bridge, was predicted to increase binding affinity by stabilizing the inhibitor in a bound conformation. Unexpectedly, a structure-based search revealed that our hypothesized backbone-stabilized PhAH bears strong similarity to SF2312, a phosphonate antibiotic of unknown mode of action produced by the actinomycete Micromonospora, which is active under anaerobic conditions. Here, we present multiple lines of evidence, including a novel X-ray structure, that SF2312 is a highly potent, low-nanomolar inhibitor of enolase.

MeSH terms

  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology*
  • Humans
  • Models, Molecular
  • Molecular Structure
  • Organophosphonates / chemistry
  • Organophosphonates / pharmacology*
  • Phosphopyruvate Hydratase / antagonists & inhibitors*
  • Phosphopyruvate Hydratase / metabolism
  • Pyrrolidinones / chemistry
  • Pyrrolidinones / pharmacology*
  • Structure-Activity Relationship

Substances

  • (1,5-dihydroxy-2-oxopyrrolidin-3-yl)phosphonic acid
  • Enzyme Inhibitors
  • Organophosphonates
  • Pyrrolidinones
  • Phosphopyruvate Hydratase

Associated data

  • PubChem-Substance/317230099
  • PubChem-Substance/317230108
  • PubChem-Substance/317230109
  • PubChem-Substance/317230110
  • PubChem-Substance/317230111
  • PubChem-Substance/317230112
  • PubChem-Substance/317230113
  • PubChem-Substance/317230114
  • PubChem-Substance/317230115
  • PubChem-Substance/317230100
  • PubChem-Substance/317230101
  • PubChem-Substance/317230102
  • PubChem-Substance/317230103
  • PubChem-Substance/317230104
  • PubChem-Substance/317230105
  • PubChem-Substance/317230106
  • PubChem-Substance/317230107